606 related articles for article (PubMed ID: 28914371)
1. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C: A Promising Marker of Renal Function in Patients with Systemic Lupus Erythematosus?
Peixoto L; Aguiar P; de Bragança R; Martins JR; Acabado AJ; Ducla-Sores JL
Acta Med Port; 2015; 28(3):333-41. PubMed ID: 26421786
[TBL] [Abstract][Full Text] [Related]
3. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
[TBL] [Abstract][Full Text] [Related]
4. Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients.
Valero-Gonzalez S; Castejon R; Jimenez-Ortiz C; Rosado S; Tutor-Ureta P; Vargas JA; Yebra-Bango M
Scand J Rheumatol; 2014; 43(1):54-8. PubMed ID: 24050535
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.
Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN
Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.
Lertnawapan R; Bian A; Rho YH; Raggi P; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
Lupus; 2012 Mar; 21(3):279-87. PubMed ID: 22072023
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
[TBL] [Abstract][Full Text] [Related]
9. Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients.
Mellor-Pita S; Tutor-Ureta P; Rosado S; Alkadi K; Granado F; Jimenez-Ortiz C; Castejon R
Clin Rheumatol; 2019 Apr; 38(4):1177-1186. PubMed ID: 30628012
[TBL] [Abstract][Full Text] [Related]
10. Relationship between renal volume and atherosclerosis in nondiabetic hypertensive patients with normal glomerular filtration rate.
Selvi E; Aybal Kutlugun A; Tangal NG; Murat K; Akkan T; Beyan E; Ramadan Uysal S
Clin Exp Hypertens; 2021 May; 43(4):373-377. PubMed ID: 33602005
[No Abstract] [Full Text] [Related]
11. Cystatin C: a step forward in assessing kidney function and cardiovascular risk.
Lassus J; Harjola VP
Heart Fail Rev; 2012 Mar; 17(2):251-61. PubMed ID: 21431356
[TBL] [Abstract][Full Text] [Related]
12. Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.
Sabio JM; Vargas-Hitos JA; Mediavilla JD; Navarrete-Navarrete N; Zamora-Posadas M; Pérez-Vicente S; Hidalgo-Tenorio C; Díaz-Chamorro A; Jáimez L; Jiménez-Alonso J;
Lupus; 2010 Apr; 19(5):591-8. PubMed ID: 20179170
[TBL] [Abstract][Full Text] [Related]
13. Cumulated organ damage is associated with arterial stiffness in women with systemic lupus erythematosus irrespective of renal function.
Sabio JM; Vargas-Hitos JA; Martínez-Bordonado J; Navarrete-Navarrete N; Díaz-Chamorro A; Olvera-Porcel C; Jiménez-Alonso J
Clin Exp Rheumatol; 2016; 34(1):53-7. PubMed ID: 26812222
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus.
Castejon R; Jimenez-Ortiz C; Rosado S; Tutor-Ureta P; Mellor-Pita S; Yebra-Bango M
Lupus; 2016 Feb; 25(2):129-36. PubMed ID: 26359174
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
Dupont M; Wu Y; Hazen SL; Tang WH
Circ Heart Fail; 2012 Sep; 5(5):602-9. PubMed ID: 22899766
[TBL] [Abstract][Full Text] [Related]
16. Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries.
Erlandsen EJ; Hansen RM; Randers E; Petersen LE; Abrahamsen J; Johannesen IL
Spinal Cord; 2012 Oct; 50(10):778-83. PubMed ID: 22547045
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults.
Rodondi N; Yerly P; Gabriel A; Riesen WF; Burnier M; Paccaud F; Bovet P
Nephrol Dial Transplant; 2007 Apr; 22(4):1107-14. PubMed ID: 17205961
[TBL] [Abstract][Full Text] [Related]
18. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum cystatin C and markers of subclinical atherosclerosis in hypertensive patients.
Monteiro Junior Fd; Ferreira PA; Nunes JA; Cunha Júnior CP; Brito RL; Costa JH; Lima JR; Lages JS; Salgado Filho N; Lima VC
Arq Bras Cardiol; 2012 Oct; 99(4):899-906. PubMed ID: 22936030
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.
Kim DJ; Kang HS; Choi HS; Cho HJ; Kim ES; Keum B; An H; Kim JH; Seo YS; Kim YS; Yim HJ; Jeen YT; Lee HS; Um SH; Kim CD; Ryu HS
Korean J Hepatol; 2011 Jun; 17(2):130-8. PubMed ID: 21757984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
